Australia invests further $14.6 million in national allergy research
Australian Government funding until June 2028 of a further $14.6 million for the National Allergy Centre of Excellence…
Real-World Evidence Supports Clinical Effectiveness of neffy® (epinephrine nasal spray) in Patients Experiencing Anaphylaxis
ARS Pharmaceuticals, Inc. Findings accepted for publication in the official journal of the American College of Allergy, Asthma…
FDA Confirms Direct Review Path For Aquestive’s Allergy Treatment
The U.S. Food and Drug Administration (FDA) on Thursday informed Aquestive Therapeutics, Inc. (NASDAQ:AQST) that an advisory committee…
Common allergy medication’s risks outweigh its usefulness, experts say
AND ON THE SEACOAST, 95 AND 101 ARE DELAY FREE. THIS CAN BE A TOUGH TIME OF YEAR…
Common allergy medication’s risks outweigh its usefulness, experts say
AND ON THE SEACOAST, 95 AND 101 ARE DELAY FREE. THIS CAN BE A TOUGH TIME OF YEAR…